Submitted by Administrator on Thu, 07/11/2019 - 17:09
On 04 November 2019, Cancer Research UK announced a £56m investment in CRUK RadNet, their largest ever investment in radiotherapy research.
CRUK RadNet is a national network of 7 centres of excellence in radiation research.
It unites the universities of Cambridge, Glasgow, Leeds, Manchester and Oxford, the CRUK City of London Centre and the Institute of Cancer Research in partnership with the Royal Marsden NHS Foundation Trust, London.
The network will accelerate investigation into therapies including FLASH, proton beam, precision medicine and combination therapies.
Of this investment, £13m will go to support new research groups and fund 
additional PhD students in Manchester, London and Cambridge.
Additionally, a share of £4m is available to all centres for joint research projects, conferences and secondments between locations.
Charlotte Coles (Department of Oncology and CRUK Cambridge Centre Breast Cancer Programme) has been appointed lead for Cancer Research UK RadNet Cambridge Radiation Research Centre of Excellence.